Assessment of Fibrin Degradation Products During Fibrinolytic Therapy for Acute Myocardial Infarction

Circulation - United States
doi 10.1161/01.cir.74.5.1027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)